An interventional study of Transforaminal Epidural Steroid Injections in Lumbar Redicular Pain, sponsored by Muhammad Aamir Latif. Completed at 1 site in Pakistan. Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-24.
Sponsored by Muhammad Aamir Latif · Not applicable, Interventional, and Treatment
Back pain is the most common chronic pain disorder of adult population. Lumbar radicular pain occurs due to irritation or compression of the nerve roots in the lower back. Various non-surgical methods can also be exercised that have been used to treat lumbar radicular pain since the ancient times. Despite the availability of various treatment options, achieving optimal pain relief and functional recovery remains challenging. Lumbar Transforaminal Epidural Steroid Injections (TFESI) are commonly used to manage this condition, but there is variability in patient response and limited data on the effectiveness of TFESI in different demographic and clinical subgroups.
Muhammad Aamir Latif is the lead sponsor of 56 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Lumbar Transforaminal Epidural Steroid Injections was administered, consisting of 4 mg dexamethasone and 0.33% lidocaine in a 3 ml solution.
Drug: Transforaminal Epidural Steroid Injections
Transforaminal Epidural Steroid Injections
Also known as: Lumbar transforaminal epidural steroid Injection was administered, consisting of 4 mg dexamethasone and 0.33% lidocaine in a 3 ml solution
Pain score
Patients were monitored for four weeks post-treatment, with follow-up visits scheduled at 1 week and 4 weeks. Pain scores were reassessed using visual analog scale (scores between 1 to 10). Lower scores meant lower pain whereas higher scores meant higher degree of pain
Time frame: 4-week
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Muhammad Aamir Latif